Alphatec Holdings, Inc.
ATECHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The $1.39B market capitalization puts ATEC squarely in small-cap range for its industry. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Market Cap
$1.39B
Beta
0.85
P/E (TTM)
—
P/E (Fwd)
15.61
EPS (TTM)
$-0.84
EPS (Fwd)
$0.58
ROE
—
ROA
-3.8%
Cash
$139.9M
Total Debt
$603.1M
Free CF
$54.6M
52W Change
-15.0%
Annual Financials
Cash vs Debt
The company holds $139.9M in cash, though total debt stands at $603.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $54.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Revenue has grown from $243.2M (2021) to $764.2M (2025), reflecting a 214% increase over the period.
Investors considering Alphatec Holdings, Inc. should weigh the typical risks associated with ATEC's sector, size, and financial profile against their own risk tolerance and investment objectives. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Alphatec Holdings, Inc. and its sector.